(Q46854672)

English

Transfusion-transmitted viral infections: building bridges to transfusion medicine to reduce risks and understand epidemiology and pathogenesis

scientific article published in September 2006

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16965593

Transfusion-transmitted viral infections: building bridges to transfusion medicine to reduce risks and understand epidemiology and pathogenesis (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16965593

Michael P. Busch

1

object named as

Michael P Busch

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

publication date

1 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16965593

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16965593

46

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16965593

9

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16965593

1624-1640

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16965593

Paid-versus-volunteer blood donation in the United States: a historical review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

A "NEW" ANTIGEN IN LEUKEMIA SERA

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Correlation of Australia Antigen With Posttransfusion Hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Serologic evidence of hepatitis A and B virus infections in thalassemia patients: a retrospective study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Non-A, non-B post-transfusion hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

HCV viral load in anti‐HCV‐reactive donors and infectivity for their recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Viral and host factors in early hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Prevalence of antibodies to human immunodeficiency virus type 1 among blood donors prior to screening. The Transfusion Safety Study/NHLBI Donor Repository

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV-1 antibody screening. The Transfusion Safety Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

How well has self-exclusion worked?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion. Transfusion Safety Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Human immunodeficiency virus type 1 infection: relationship of risk group and age to rate of progression to AIDS. Transfusion Safety Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Epidemiologic background and long-term course of disease in human immunodeficiency virus type 1-infected blood donors identified before routine laboratory screening. Transfusion Safety Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Comparative rates of disease progression among persons infected with the same or different HIV-1 strains. The Transfusion Safety Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Divergence of HIV-1 quasispecies in an epidemiologic cluster

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

The Viral Activation Transfusion Study (VATS): rationale, objectives, and design overview

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-1 and HTLV-I/II infections.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Antigen testing for human immunodeficiency virus (HIV) and the magnet effect: will the benefit of a new HIV test be offset by the numbers of higher risk, test-seeking donors attracted to blood centers? Retrovirus Epidemiology Donor Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Two percent of HIV-positive U.S. blood donors are infected with non-subtype B strains.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Surveillance of the genetic variation in incident HIV, HCV, and HBV infections in blood and plasma donors: implications for blood safety, diagnostics, treatment, and molecular epidemiology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

False-negative testing errors in routine viral marker screening of blood donors. For the Retrovirus Epidemiology Donor Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

International application of the incidence rate/window period model.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: comparison of second- and third-generation anti-HCV assays

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Dynamics of viremia in early hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Analysis of HBV infection after blood transfusion in Japan through investigation of a comprehensive donor specimen repository

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Estimated risk of transfusion-transmitted viral infections in Spain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Trends in residual risk of transfusion-transmitted viral infections in France between 1992 and 2000.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood in Italy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first-time blood donors in São Paulo, Brazil

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Prevalence of HIV-1 in blood donations following implementation of a structured blood safety policy in South Africa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

HIV seroconverting donors delay their return: screening test implications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Results of viral marker screening of unpaid blood donations and probability of window period donations in 1997. EPFA Working Group on Quality Assurance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Granulocyte transfusion: a review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

The impact of male-to-male sexual experience on risk profiles of blood donors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Evaluation of the de-selection of men who have had sex with men from blood donation in England

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

The 2003 West Nile virus United States epidemic: the America's Blood Centers experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

West Nile virus among blood donors in the United States, 2003 and 2004.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Problem solved? West Nile virus and transfusion safety

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00957.X

21 January 2018

Identifiers

10.1111/J.1537-2995.2006.00957.X

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16965593

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16965593

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46854672&oldid=2134760268"